Login

Anders Rabbe, CEO, Isofol Medical AB (publ) 00:00:00

Share On Facebook Share On Twitter

Isofol Medical at Pareto Securities' Health Care Conference

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Deciphering Market Volatility: Dispelling Parallels with the GFC | Mike Gitlin, CEO , Capital Group Companies Inc.
00:10:00
Elevate Uranium Sets Stage for Breakthrough with Low-Cost, High-Grade Processing in Namibia|Murray Hill,CEO,Elevate Uranium
00:10:00
Overcoming Adversity: Frank Castellano's Journey with Neurodiversity and Community Support
00:10:00
Copper Market Outlook: Post-COVID-19 Recovery and Future Projections
00:00:00
Commercializing products in the musculoskeletal segment of the marketplace - Adam Gridley, President and CEO, Histogenics Corp
00:10:00
After November 3, 2021, Mechanical Technologies (NASDAQ: MKTY) became Soluna Holdings (NASDAQ: SLNH), as announced by CEO Michael Toporek and John..|John Belizaire is Chief Executive Officer & Director, Soluna Holdings, Inc.
00:10:00
CompoSecure at FinovateEurope 2023 - cybersecurity threats in payments | Jonathan Wilk, CEO, CompoSecure IncCMPO:NMQ
00:10:00
CPI Report Analysis and Market Response | Rob McDougle, Vice-President, Zhang Financial.
00:10:00
Invests in companies all over the world working on tools that improve remote work|Andreas Klinger,General Partner,Remote First Capital
00:10:00
Exploring Energy Transition: Insights from Jim Hughes at EnCap Investments | Jim Hughes, Managing Partner, EnCap Investments.
00:10:00
Deciphering the DeClout Blueprint: Navigating the Path to Success | Vesmond Wong , CEO of DeClout Ltd
00:10:00
Gavin Nixon Highlights Arafura Resources' Development of the Nolans Project

© 2026 Nehu